Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy.
Single-cell RNA sequencing in donor and end-stage heart failure patients identifies NLRP3 as a therapeutic target for arrhythmogenic right ventricular cardiomyopathy.
复制标题
供体和终末期心力衰竭患者的单细胞RNA测序将NLRP 3鉴定为致瘤性右心室心肌病的治疗靶点
DOI:
10.1186/s12916-023-03232-8
复制
发表时间:
2024-01-08
期刊:
影响因子:
9.3
通讯作者:
Song, Jiangping
中科院分区:
文献类型:
--
作者:
Fu, Mengxia;Hua, Xiumeng;Shu, Songren;Xu, Xinjie;Zhang, Hang;Peng, Zhiming;Mo, Han;Liu, Yanyun;Chen, Xiao;Yang, Yicheng;Zhang, Ningning;Wang, Xiaohu;Liu, Zirui;Yue, Guangxin;Hu, Shengshou;Song, Jiangping
Dilation may be the first right ventricular change and accelerates the progression of threatening ventricular tachyarrhythmias and heart failure for patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), but the treatment for right ventricular dilation remains limited. Single-cell RNA sequencing (scRNA-seq) of blood and biventricular myocardium from 8 study participants was performed, including 6 end-stage heart failure patients with ARVC and 2 normal controls. ScRNA-seq data was then deeply analyzed, including cluster annotation, cellular proportion calculation, and characterization of cellular developmental trajectories and interactions. An integrative analysis of our single-cell data and published genome-wide association study-based data provided insights into the cell-specific contributions to the cardiac arrhythmia phenotype of ARVC. Desmoglein 2 (Dsg2)mut/mut mice were used as the ARVC model to verify the therapeutic effects of pharmacological intervention on identified cellular cluster. Right ventricle of ARVC was enriched of CCL3+ proinflammatory macrophages and TNMD+ fibroblasts. Fibroblasts were preferentially affected in ARVC and perturbations associated with ARVC overlap with those reside in genetic variants associated with cardiac arrhythmia. Proinflammatory macrophages strongly interact with fibroblast. Pharmacological inhibition of Nod-like receptor protein 3 (NLRP3), a transcriptional factor predominantly expressed by the CCL3+ proinflammatory macrophages and several other myeloid subclusters, could significantly alleviate right ventricular dilation and dysfunction in Dsg2mut/mut mice (an ARVC mouse model). This study provided a comprehensive analysis of the lineage-specific changes in the blood and myocardium from ARVC patients at a single-cell resolution. Pharmacological inhibition of NLRP3 could prevent right ventricular dilation and dysfunction of mice with ARVC. The online version contains supplementary material available at 10.1186/s12916-023-03232-8.
登录
查看更多内容
影响因子:
14.8
作者:
Kumar, Prateek;Henikoff, Steven;Ng, Pauline C.
通讯作者:
Ng, Pauline C.
影响因子:
14.9
作者:
Buniello, Annalisa;MacArthur, Jacqueline A. L.;Parkinson, Helen
通讯作者:
Parkinson, Helen
影响因子:
30.8
作者:
Kircher, Martin;Witten, Daniela M.;Jain, Preti;O'Roak, Brian J.;Cooper, Gregory M.;Shendure, Jay
通讯作者:
Shendure, Jay
影响因子:
8
作者:
Chelko, Stephen P.;Asimaki, Angeliki;Judge, Daniel P.
通讯作者:
Judge, Daniel P.
影响因子:
64.5
作者:
Gruber, Conor N.;Patel, Roosheel S.;Bogunovic, Dusan
通讯作者:
Bogunovic, Dusan